Clinical diagnosis of vascular dementia

Ken Nagata1, Hirohiko Saito, Tomoyuki Ueno

  • 1Department of Neurology, Research Institute for Brain and Blood Vessels, 6-10 Sesnshu-Kubota-Machi Akita 010-0874, Japan. nagata@akita-noken.go.jp

Insights

Vascular dementia (VaD) diagnosis needs updates, incorporating advanced imaging like SPECT. Recognizing mixed dementia, such as Alzheimer's disease with cerebrovascular disease (CVD), is crucial for accurate clinical assessment.

Area of Science:

  • Neurology
  • Neuroscience
  • Geriatrics

Background:

  • Vascular dementia (VaD) is a complex condition resulting from cerebrovascular disease (CVD).
  • Current diagnostic criteria for VaD are over a decade old and require modernization.
  • Existing diagnostic approaches often create a false dichotomy between VaD and Alzheimer's disease (AD).

Purpose of the Study:

  • To highlight the need for updated diagnostic criteria for Vascular dementia (VaD).
  • To emphasize the importance of integrating functional brain imaging, such as SPECT, into VaD diagnosis.
  • To advocate for the inclusion of mixed dementia concepts, like "AD with CVD," in clinical practice.

Main Methods:

  • Review of current diagnostic criteria for Vascular dementia (VaD).
  • Discussion on the limitations of existing diagnostic dichotomies.
  • Exploration of the potential role of functional neuroimaging (e.g., SPECT) in diagnosis.

Main Results:

  • Current VaD diagnostic criteria are outdated.
  • Functional brain imaging methods like SPECT can enhance diagnostic accuracy.
  • The strict separation between AD and VaD is insufficient for many patients.

Conclusions:

  • Diagnostic criteria for Vascular dementia (VaD) must be renovated.
  • Functional neuroimaging should be integrated into the diagnostic process for VaD.
  • Clinical diagnosis of VaD should incorporate the concept of mixed dementia, including "AD with CVD."

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...